Clinical Resource Core
临床资源核心
基本信息
- 批准号:10392978
- 负责人:
- 金额:$ 14.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AdolescentAdultAgeAreaAutoantibodiesAutoimmunityBackBasic ScienceBeta CellBioinformaticsBiologicalBiological AssayBiostatistical MethodsBlood specimenCardiovascular DiseasesCellsCenter for Translational Science ActivitiesChildChildhood diabetesClinicClinicalClinical DataClinical ResearchCollaborationsColoradoCommunicationComplications of Diabetes MellitusComputerized Medical RecordConsultCore FacilityCross-Sectional StudiesDataData LinkagesData Management ResourcesDatabasesDevelopmentDiabetes MellitusDiabetic NephropathyDiagnosticDiseaseEconomic BurdenEquipmentFacultyFaculty RecruitmentFosteringFunctional disorderFundingGestational DiabetesGoalsGrantGrowthHealthHospitalsHuman ResourcesHyperglycemiaImprove AccessIncidenceIndividualInfantInfrastructureInstitutionInsulin ResistanceInsulin-Dependent Diabetes MellitusInvestigationLaboratoriesLogisticsLongevityLongitudinal StudiesMedicalMedical centerMetabolic dysfunctionMolecular AnalysisMorbidity - disease rateMothersNon-Insulin-Dependent Diabetes MellitusOutcomeParticipantPatient RecruitmentsPatientsPediatric HospitalsPersonsPhenotypePhysiciansPlasmaPopulationProcessProductivityProtocols documentationRegistriesResearchResearch DesignResearch InfrastructureResearch PersonnelResource SharingResourcesSECTM1 geneSamplingScientistSerumServicesStatistical Data InterpretationTalentsTeacher Professional DevelopmentTechniquesTechnologyTestingTissue SampleTrainingTranslational ResearchUnited States Department of Veterans AffairsUnited States National Institutes of HealthUniversitiesanalytical toolbench-to-bedside translationbiobankclinical careclinical centercystic fibrosis related diabetesdata warehousediabetes controldiabetes riskdiabeticeligible participantgenetic analysishuman leukocyte antigen testingimprovedinterestmetabolic phenotypemortalitynon-diabeticpatient registryperipheral bloodpreventprogramsrecruitrepositoryresearch facilitysample collectiontype I and type II diabetes
项目摘要
CLINICAL RESOURCE CORE
PROGRAM SUMMARY/ABSTRACT
Diabetes represents a worldwide health crisis, with the incidence of both type 1 diabetes (T1D) and type 2
diabetes (T2D) steadily increasing. While autoimmunity is central to T1D, many key aspects of the disease
process are shared by T1D and T2D, including beta cell dysfunction, hyperglycemia, metabolic dysfunction and
insulin resistance. Complications of T1D and T2D also have many similarities, including cardiovascular disease
(CVD) and diabetic kidney disease (DKD), both leading causes of morbidity and mortality. The University of
Colorado Anschutz Medical Center (UC AMC) is among world leaders in clinical translational investigations into
T1D and T2D across the lifespan, as well as in gestational diabetes (GDM) and cystic fibrosis-related diabetes
(CFRD). Funding through the Diabetes Research Center (DRC) would capitalize on these existing
strengths and catalyze the formation of an integrated comprehensive diabetes research program.
The Clinical Resource Core (CR) of the UC Denver DRC stands at the interface of multiple institutions, programs
and individuals, all of whom are working to prevent or ameliorate the devastating long term complications of
diabetes and its high economic burden. The CR core would leverage the current clinical research facilities and
equipment available at the Barbara Davis Center for Childhood Diabetes (BDC), UC AMC’s Clinical Translational
Research Center (CTRC), The University of Colorado Hospital, Denver Veteran’s Administration Medical Center
(VA) and Children’s Hospital Colorado. The DRC CR core would integrate diabetes research across these
institutions through communication and distribution of the resources available, and create shared sample and
data biobanks and a recruiting database of mothers, infants, children, adolescents and adults with diabetes,
diabetes risk and controls. Such integration would accelerate progress and increase the quality of diabetes
research, coalesce existing strengths and strategically focus faculty recruitment in areas of needed
growth. DRC funding would also attract new talent at postgraduate and junior faculty levels and add
unique components of infrastructure needed for discovery.
Specifically, we will improve access and collaborations for recruiting subjects, tracking data and banking tissue
samples from well-phenotyped participants with diabetes and control subjects across the lifespan; establish
collections of samples from our well-characterized subjects and facilitate the ability of DRC users to perform
assays from peripheral blood, serum and plasma utilizing state of the art techniques; improve provision of
specialized diagnostic and analytic services.
临床资源核心
程序摘要/摘要
糖尿病代表着全球的健康危机,其中1型糖尿病(T1D)和2型事件
糖尿病(T2D)稳步增加。尽管自身免疫性是T1D的核心,但疾病的许多关键方面
过程由T1D和T2D共享,包括β细胞功能障碍,高血糖,代谢功能障碍和
胰岛素抵抗。 T1D和T2D的并发症也有许多相似之处,包括心血管疾病
(CVD)和糖尿病肾病(DKD),都是发病率和死亡率的主要原因。大学
科罗拉多州安索斯医学中心(UC AMC)是临床转化调查中的世界领导者
T1D和T2D遍布整个寿命,以及妊娠糖尿病(GDM)和囊性纤维化相关糖尿病
(CFRD)。通过糖尿病研究中心(DRC)的资金将利用这些现有
优势并催化综合综合糖尿病研究计划的形成。
UC Denver DRC的临床资源核心(CR)位于多个机构的界面,程序
和所有人都在努力预防或改善毁灭性的长期并发症
糖尿病及其巨大的经济负担。 CR核心将利用当前的临床研究设施和
UC AMC的临床翻译
研究中心(CTRC),科罗拉多大学医院,丹佛资深管理医疗中心
(VA)和科罗拉多州儿童医院。 DRC CR核心将整合这些糖尿病研究
通过通信和分配可用资源的机构,并创建共享样本和
数据生物库和母亲,婴儿,儿童,青少年和成年人的招募数据库,
糖尿病风险和控制。这种整合将加速进步并提高糖尿病的质量
研究,合并现有的优势,并从战略上关注教师的招聘
生长。刚果民主共和国的资金还将吸引研究生和初级教师级别的新人才,并添加
发现所需的基础架构的独特组成部分。
具体来说,我们将改善招聘主题,跟踪数据和银行组织的访问和协作
来自整个寿命的糖尿病和对照受试者的良好表现的参与者的样本;已确立的
来自我们特定的主题的样本收集,并促进了刚果民主共和国用户的能力
利用艺术技术的状态的外周血,血清和血浆的测定;改善提供
专门的诊断和分析服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARIAN J REWERS其他文献
MARIAN J REWERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARIAN J REWERS', 18)}}的其他基金
Developing Pediatric Diabetes Investigators for the Future
培养未来的儿科糖尿病研究人员
- 批准号:
9188204 - 财政年份:2011
- 资助金额:
$ 14.44万 - 项目类别:
Integrated Cardio-Renal Risk Prediction Models in Type 1 Diabetes
1 型糖尿病的综合心肾风险预测模型
- 批准号:
7829755 - 财政年份:2010
- 资助金额:
$ 14.44万 - 项目类别:
CORONARY ARTERY CALCIFICATION IN TYPE I DIABETES
I 型糖尿病的冠状动脉钙化
- 批准号:
7719420 - 财政年份:2008
- 资助金额:
$ 14.44万 - 项目类别:
DETERMINANTS OF INSULIN SENSITIVITY IN TYPE 1 DIABETES
1 型糖尿病胰岛素敏感性的决定因素
- 批准号:
7719498 - 财政年份:2008
- 资助金额:
$ 14.44万 - 项目类别:
DETERMINANTS OF INSULIN SENSITIVITY IN TYPE 1 DIABETES
1 型糖尿病胰岛素敏感性的决定因素
- 批准号:
7604448 - 财政年份:2007
- 资助金额:
$ 14.44万 - 项目类别:
CORONARY ARTERY CALCIFICATION IN TYPE I DIABETES
I 型糖尿病的冠状动脉钙化
- 批准号:
7604370 - 财政年份:2007
- 资助金额:
$ 14.44万 - 项目类别:
DETERMINANTS OF INSULIN SENSITIVITY IN TYPE 1 DIABETES
1 型糖尿病胰岛素敏感性的决定因素
- 批准号:
7377862 - 财政年份:2006
- 资助金额:
$ 14.44万 - 项目类别:
The 10th Symposium of the International Diabetes Epidemiology Group - a Satellite
国际糖尿病流行病学组第十次研讨会-卫星会
- 批准号:
7282213 - 财政年份:2006
- 资助金额:
$ 14.44万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
HealthyU-Latinx: A Technology-based Tool for addressing Health Literacy in Latinx Secondary Students and their Families
HealthyU-Latinx:一种基于技术的工具,用于提高拉丁裔中学生及其家庭的健康素养
- 批准号:
10699830 - 财政年份:2023
- 资助金额:
$ 14.44万 - 项目类别:
Probiotic Administration for Adolescent Depression
益生菌治疗青少年抑郁症
- 批准号:
10646130 - 财政年份:2023
- 资助金额:
$ 14.44万 - 项目类别: